UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial

JAMA neurology, 2020-08, Vol.77 (8), p.966

2020

Volltextzugriff (PDF)

Selepressin for Patients With Septic Shock-Reply

JAMA : the journal of the American Medical Association, 2020-02, Vol.323 (7), p.667

2020

Volltextzugriff (PDF)

Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Circulation (New York, N.Y.), 2011-09, Vol.124 (11), p.1250-1259

ACT Investigators

2011

Volltextzugriff (PDF)

Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery

Journal of the American Society of Nephrology, 2018-01, Vol.29 (1), p.260-267

2018

Volltextzugriff (PDF)

Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study

Annals of internal medicine, 2022-03, Vol.175 (3), p.325

2022

Volltextzugriff (PDF)

Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study

The lancet. Diabetes & endocrinology, 2020-09, Vol.8 (9), p.773-781

2020

Volltextzugriff (PDF)

Implantable cardioverter-defibrillator prescription in the elderly

Heart rhythm, 2009-08, Vol.6 (8), p.1136-1143

2009

Volltextzugriff (PDF)

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

The New England journal of medicine, 2018-09, Vol.379 (11), p.1007-1016

2018

Volltextzugriff (PDF)

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Neurology, 2009-02, Vol.72 (6), p.535

2009

Volltextzugriff (PDF)

Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-08, Vol.324 (7), p.642

2020

Volltextzugriff (PDF)

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

The Lancet (British edition), 2022-07, Vol.400 (10347), p.161-169

2022

Volltextzugriff (PDF)

Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis

The New England journal of medicine, 2016-03, Vol.374 (11), p.1011-1020

2016

Volltextzugriff (PDF)

1840-P: Pioglitazone Increases Metabolic Insulin Clearance (MCRI) in IGT Subjects: The ACT NOW Study

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go – Authors' reply

The lancet. Diabetes & endocrinology, 2020-11, Vol.8 (11), p.877-878

2020

Volltextzugriff (PDF)

Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults

The New England journal of medicine, 2023-10, Vol.389 (15), p.1357-1367

2023

Volltextzugriff (PDF)

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1373-1385

2017

Volltextzugriff (PDF)

Trial participants’ experiences of early enhanced speech and language therapy after stroke compared with employed visitor support: a qualitative study nested within a randomized controlled trial

Clinical rehabilitation, 2013-02, Vol.27 (2), p.174-182

2013

Volltextzugriff (PDF)

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Circulation. Heart failure, 2017-06, Vol.10 (6)

2017

Volltextzugriff (PDF)

Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data

Multiple sclerosis, 2008-04, Vol.14 (3), p.370-382

2008

Volltextzugriff (PDF)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Trials, 2009-06, Vol.10 (38), p.38-38, Article 38

2009

Volltextzugriff (PDF)

Machine learning to predict rapid progression of carotid atherosclerosis in patients with impaired glucose tolerance

EURASIP journal on bioinformatics & systems biology, 2016-12, Vol.2016 (1), p.14-7, Article 14

2016

Volltextzugriff (PDF)

Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)

Health technology assessment (Winchester, England), 2012-05, Vol.16 (26), p.1-160

2012

Volltextzugriff (PDF)

Abstract 15947: Machine Learning to Predict Rapid Progression of Carotid Atherosclerosis in Patients With Impaired Glucose Tolerance in the ACT NOW Study

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A15947-A15947

2015

Volltextzugriff (PDF)

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

Journal of cachexia, sarcopenia and muscle, 2011-12, Vol.2 (4), p.201-207

2011

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)

Sprache

Japanisch
(7)
Türkisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial

Selepressin for Patients With Septic Shock-Reply

Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)

Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery

Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study

Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study

Implantable cardioverter-defibrillator prescription in the elderly

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS

Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial

Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis

1840-P: Pioglitazone Increases Metabolic Insulin Clearance (MCRI) in IGT Subjects: The ACT NOW Study

Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go – Authors' reply

Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Trial participants’ experiences of early enhanced speech and language therapy after stroke compared with employed visitor support: a qualitative study nested within a randomized controlled trial

Abstract WMP11: Health-related Quality Of Life After Thrombolysis In Acute Stroke: Results From The Act Trial

Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)

Avonex Combination Trial in relapsing—remitting MS: rationale, design and baseline data

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

Machine learning to predict rapid progression of carotid atherosclerosis in patients with impaired glucose tolerance

Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)

Abstract 15947: Machine Learning to Predict Rapid Progression of Carotid Atherosclerosis in Patients With Impaired Glucose Tolerance in the ACT NOW Study

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design

Aktive Filter

Suchergebnisse filtern